India Reaches 80 Lakh Milestone in National HPV Rollout
India has achieved a major public health milestone by surpassing 80 lakh doses in its ongoing HPV vaccination drive. Therefore, healthcare providers across the country are witnessing a significant push toward eliminating cervical cancer. The Union Health Ministry launched this nationwide campaign on February 28 to protect girls aged 14 years. Consequently, public facilities now deliver targeted prophylaxis against high-risk oncogenic strains before sexual debut occurs.
Operational Framework of the HPV Vaccination Drive
Under this initiative, government facilities administer the single-dose Gardasil-4 vaccine completely free of charge. Specifically, services operate through Ayushman Arogya Mandirs, primary health centres, community health centres, and district hospitals. Furthermore, government medical colleges provide advanced institutional support during routine immunization days. Beneficiaries must obtain parental consent before receiving the vaccine. In addition, healthcare teams record all immunizations on the digital U-WIN platform to ensure seamless tracking.
Clinical Safety and Rigorous AEFI Monitoring
Safety remains central to the nationwide immunization protocol. Thus, qualified medical officers directly oversee every vaccination session across participating centres. Additionally, each vaccination site maintains direct linkage to 24x7 adverse events following immunization (AEFI) management units. Medical officers receive specialized training to address rare adverse reactions swiftly. As a result, parents and clinicians can maintain high confidence in vaccine safety.
State-Level Leadership and Public Health Impact
Several states demonstrate exemplary momentum in driving adolescent immunization rates. For example, Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Gujarat, Odisha, and Mizoram currently lead nationwide implementation. Moreover, local health authorities actively coordinate with schools and frontline community health workers. Consequently, outreach teams bridge awareness gaps and dispel common vaccine hesitancy myths. Clinicians emphasize that early vaccination delivers robust, long-lasting immunity against human papillomavirus serotypes 16 and 18.
Frequently Asked Questions
Q1: Which vaccine does the national HPV campaign utilize, and what is the schedule?
The campaign provides a single dose of the quadrivalent Gardasil-4 vaccine. Furthermore, government centres offer this vaccine free of cost to 14-year-old girls.
Q2: How do beneficiaries register for the government HPV vaccination drive?
Families can register beneficiaries through the digital U-WIN platform. Alternatively, they can walk into designated public facilities with mandatory parental consent.
Q3: How are adverse events managed during the vaccination drive?
Trained medical officers supervise every session directly. Additionally, all centres connect with 24x7 AEFI management facilities to handle rare adverse reactions promptly.
References
- India crosses 80 lakh HPV vaccinations in nationwide cervical cancer preventiondrive - ETHealthworld
- Press Information Bureau, Government of India. Nationwide HPV Vaccination Campaign for 14-Year-Old Girls.
- World Health Organization. One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer.
